… macrophages of asthmatic patients after an inhaled glucocorticoid and inhaled long-acting β
2 -… with oral corticosteroids increase the risk of posterior subcapsular cataracts and there are …

… , long-term use of high doses of ICS carries the risk of systemic side effects, such as cataract,
glaucoma, diabetes, bone fractures, and pneumonia [25]. These ICS-related complications …

… 4.2 Cataracts and Glaucoma Randomised controlled trials to evaluate the effects of inhaled
corticosteroids on cataract and glaucoma risk are lacking. Several high-profile observational …

… given during the first 4 years of the study, including inhaled corticosteroids. The study is
in its final year and has received three reports of suspected or definite posterior subcapsular …

… As with other datasets we have shown that ICS use is associated with cataract surgery but
… was that fluticasone was more strongly associated with cataract surgery than other ICS, it is …

… corticosteroids increases the risk for cataracts, it has been difficult to establish a definitive
link between ICS therapy and cataract … risk of ICS-related posterior subcapsular cataract …

… between glaucoma and cataract within the … cataract patients were at an 8.22-fold increased
risk of developing glaucoma. As a result, the intraocular pressure in this particularly high-risk …

Despite the fact that the recommendations of the main clinical guidelines have restricted the
indications for inhaled corticosteroids in chronic obstructive pulmonary disease (COPD), …

… Some large population-based studies have reported a dose-related increased risk of cataracts
and glaucoma associated with use of inhaled corticosteroids (ICS) in patients with asthma …

… of inhaled corticosteroids (ICS) on the risk of glaucoma remains uncertain. We sought to
determine the risk … The reported ocular side effects of ICS use consist of cataracts and glaucoma. …